Supernus Pharmaceuticals (NASDAQ:SUPN) Issues Quarterly Earnings Results
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) released its quarterly earnings results on Monday. The specialty pharmaceutical company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.25, Briefing.com reports. Supernus Pharmaceuticals had a net margin of 9.16% and a return on equity of 7.94%. The firm had […]
More Stories
Middlefield Banc (NASDAQ:MBCN) Rating Lowered to Sell at StockNews.com
StockNews.com downgraded shares of Middlefield Banc (NASDAQ:MBCN – Free Report) from a hold rating to a sell rating in a...
Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research note published on Sunday. The firm...
Honeywell International (NASDAQ:HON) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Honeywell International (NASDAQ:HON – Free Report) from a hold rating to a buy rating in a...
StockNews.com Initiates Coverage on Chase (NYSE:CCF)
StockNews.com began coverage on shares of Chase (NYSE:CCF – Free Report) in a research note published on Sunday. The firm...
Talanx (ETR:TLX) Trading 1.2% Higher – What’s Next?
Shares of Talanx AG (ETR:TLX – Get Free Report) shot up 1.2% on Wednesday . The company traded as high...
Albion Technology & Gen VCT (LON:AATG) Trading Up 2.1% – Should You Buy?
Albion Technology & Gen VCT (LON:AATG – Get Free Report)’s share price rose 2.1% during trading on Wednesday . The...